AUC: the total amount of drug that has entered the general circulation.
Slope: allows rates of change to be calculated.
F: the extent of absorption - biolavailability.
F = AUC oral / AUC IV
F = (AUC oral / AUC IV) X (dose IV / dose oral)
A two component model is biphasic. The initial slope determines the distribution, the second slope determines the elimination.
A one component model is monophasic and is based upon the assumption that the drug distributes to tissues very rapidly. Only elimination is occurring.
Rate of distribution (alpha): the initial rate of decrease in plasma concentrations after a dose.
Cp: the change in the concentration of drug in the plasma.
V: apparent volume of distribution - the dose divided by the plasma concentration of the drug after it has been distributed.
The gradient of the blue line is the rate of distribution. This is characteristic for a drug that depends on the rate of uptake by tissues.
C0: the plasma concentration after the drug has been fully distributed and can be calculated from the intercept of the extrapolated line.
V = dose / C0
(For a one compartment model administered by IV)
For a two-compartment model, at t = 0 little or no distribution will have occurred. Plasma concentration should only be used if distribution is instantaneous.
V = dose / y-intercept
(for a two compartment model administered by IV)
V is:
Dependent on the physiochemical properties of the drug
An indication of extent of tissue uptake
Independent of dose
Non-physiological dilution factor
Can be presented as L or L/kg
Allow for calculation of the dose necessary to give a particular plasma concentration
Rate of elimination: represented as k/min, where k is the terminal rate of decrease in plasma concentrations after either an oral or IV dose. It is characteristic for a drug.
k = CL / V
Plasma clearance (CL): the volume of plasma cleared of drug per minute or hour e.g., ml/min or L/h. Is specific for a drug. Will be similar to the blood flow for the organ via which it is eliminated.
CL plasma = CL metabolic + CL renal
CL = (dose X F) / AUC
t1/2 = 0.693 / k
Drugs that affect the activity of the liver can change the metabolic clearance - inducers will increase the CL metabolic.
Chronic administration is continuous IV infusion. This maintains a constant concentration at the site of action with a persistent therapeutic effect.
It takes 5 times the elimination half-life to reach steady state (Css).
Css = rate of infusion / CL
Css= (dose X F) / (dose interval X CL)
Multiple dosing is used to maintain a constant concentration in the blood, by repeated oral dosing.
Shorter intervals between doses produce higher Css. For drugs with long half-lives, the delay in time to steady-state concentrations may be inacceptable. The delay can be avoided by giving a large first dose (loading dose) which has the effect of topping up the apparent volume of distribution.